Abstract
A defect in invariant NKT (iNKT) cell selection was hypothesized in lysosomal storage disorders (LSD). Accumulation of glycosphingolipids (GSL) in LSD could influence lipid loading and/or presentation causing entrapment of endogenous ligand(s) within storage bodies or competition of the selecting ligand(s) by stored lipids for CD1d binding. However, when we analyzed the iNKT cell compartment in newly tested LSD animal models that accumulate GSL, glycoaminoglycans or both, we observed a defective iNKT cell selection only in animals affected by multiple sulfatase deficiency, in which a generalized aberrant T-cell development, rather than a pure iNKT defect, was present. Mice with single lysosomal enzyme deficiencies had normal iNKT cell development. Thus, GSL/glycoaminoglycans storage and lysosomal engulfment are not sufficient for affecting iNKT cell development. Rather, lipid ligand(s) or storage compounds, which are affected in those LSD lacking mature iNKT cells, might indeed be relevant for iNKT cell selection.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Count
-
Cell Differentiation / drug effects
-
Cell Differentiation / immunology*
-
Disease Models, Animal
-
Enzyme Inhibitors / pharmacology
-
Female
-
Leukodystrophy, Globoid Cell / genetics
-
Leukodystrophy, Globoid Cell / immunology
-
Leukodystrophy, Globoid Cell / pathology
-
Leukodystrophy, Metachromatic / genetics
-
Leukodystrophy, Metachromatic / immunology
-
Liver / immunology
-
Liver / pathology
-
Lymphocytes / pathology
-
Lysosomal Storage Diseases / genetics
-
Lysosomal Storage Diseases / immunology*
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Mice, Inbred Strains
-
Mice, Knockout
-
Mucopolysaccharidosis I / genetics
-
Mucopolysaccharidosis I / immunology
-
Multiple Sulfatase Deficiency Disease / genetics
-
Multiple Sulfatase Deficiency Disease / immunology
-
Multiple Sulfatase Deficiency Disease / pathology
-
Natural Killer T-Cells / immunology*
-
Natural Killer T-Cells / pathology
-
Pyrroles / pharmacology
-
Receptor, Fibroblast Growth Factor, Type 1 / antagonists & inhibitors
-
Sandhoff Disease / genetics
-
Sandhoff Disease / immunology
-
Sandhoff Disease / pathology
-
Spleen / immunology
-
Spleen / pathology
-
Thymus Gland / immunology
-
Thymus Gland / pathology
Substances
-
Enzyme Inhibitors
-
Pyrroles
-
SU 5402
-
Receptor, Fibroblast Growth Factor, Type 1